/PRNewswire/ The autism spectrum disorder therapeutics market is set to grow by USD 772.65 million from 2022 to 2027, progressing at a CAGR of 7.2% during.
Significant usage of pain management drugs, especially prescriptive medications such as non-steroidal anti-inflammatory drugs (NSAIDs), is anticipated to propel the marketWilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The global pain management therapeutics market was valued at US$ 73.6 Bn in 2021 and is projected to surpass US$ 98.0 Bn by 2031. Extensive research in personalized pain management for chronic pain in the past few years ha
Q BioMed Inc (QBIO) Issues Update to Shareholders streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical.
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant drop in short interest in May. As of May 31st, there was short interest totalling 9,600 shares, a drop of 58.1% from the May 15th total of 22,900 shares. Based on an average trading volume of 707,400 shares, the days-to-cover ratio is […]